Nucleate logo

Nucleate

North America, Michigan, United States, Brighton

Description

a collaborative venture program enabling the formation of biotechnology companies addressing climate & sustainability challenges

Investor Profile

Nucleate has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Pre Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Alternative Protein, Biotechnology, Genetics.

Stage Focus

  • Pre Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Alternative Protein
  • Biotechnology
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nucleate frequently co-invest with?

Fall Line Capital
North America, California, United States, San Mateo
Co-Investments: 1
Freeflow Ventures
North America, California, United States, Pasadena
Co-Investments: 1
Agronomics
Europe, South Lanarkshire, United Kingdom, Douglas
Co-Investments: 1
Third Derivative
North America, Colorado, United States, Boulder
Co-Investments: 1
Alpine Investors
North America, California, United States, San Francisco
Co-Investments: 1
Climate Capital Bio
North America, California, United States, San Francisco
Co-Investments: 1
Activate
North America, California, United States, Berkeley
Co-Investments: 1

What are some of recent deals done by Nucleate?

Wild Microbes

Cambridge, Massachusetts, United States

Wild Microbes is developing a microbial platform to produce faster and cheaper sustainable products from plastic to protein.

Alternative ProteinBiotechnologyGenetics
Pre SeedFeb 21, 2023
Amount Raised: $3,300,000